Concepedia

Publication | Open Access

Effect of high<i>versus</i>low dose of dexamethasone on clinical worsening in patients hospitalised with moderate or severe COVID-19 pneumonia: an open-label, randomised clinical trial

70

Citations

19

References

2021

Year

Abstract

Among hospitalised COVID-19 patients needing oxygen therapy, high dose of dexamethasone reduced clinical worsening within 11 days after randomisation, compared with low dose.

References

YearCitations

Page 1